- Home
- COF vs BSX Comparison
COF vs BSX Comparison
Compare COF & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COF | BSX |
|---|---|---|
| Founded | 1988 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8B | 149.7B |
| IPO Year | 1994 | 1992 |
Fundamental Metrics
Financial Performance| Metric | COF | BSX |
|---|---|---|
| Price | $239.39 | $91.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 19 |
| Target Price | ★ $252.12 | $124.53 |
| AVG Volume (30 Days) | 4.1M | ★ 9.8M |
| Earning Date | 01-20-2026 | 10-22-2025 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | N/A | ★ 54.68 |
| EPS | ★ 2.38 | 1.87 |
| Revenue | ★ $28,886,000,000.00 | $19,349,000,000.00 |
| Revenue This Year | $96.76 | $21.05 |
| Revenue Next Year | $18.32 | $11.43 |
| P/E Ratio | $99.87 | ★ $49.57 |
| Revenue Growth | 9.02 | ★ 21.61 |
| 52 Week Low | $143.22 | $85.98 |
| 52 Week High | $238.32 | $109.50 |
Technical Indicators
Market Signals| Indicator | COF | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 74.01 | 30.13 |
| Support Level | $228.63 | $91.86 |
| Resistance Level | $209.95 | $101.91 |
| Average True Range (ATR) | 5.54 | 2.10 |
| MACD | 2.59 | -0.89 |
| Stochastic Oscillator | 90.35 | 0.27 |
Price Performance
Historical ComparisonAbout COF Capital One Financial Corporation
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending still provides the majority of the bank's revenue.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.